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Abstract
Objectives—To examine the process of community-campus engagement in an initiative
developed to build evaluation capacities of community-based organizations (CBOs).
Methods—Evaluability assessment, capacity-building, self administered surveys and semi-
structured interviews were conducted from 2004 to 2007 and analyzed through transcript
assessment and SPSS to identify trends, relationships and capacity changes over time.
Results—Evaluability assessment identified CBO strengths in program planning and
implementation and challenges in measurable objective development, systematic use of mixed
methods, data management and analysis. Evaluability assessment informed evaluation capacity-
building (ECB) trainings, teleconferences and webinars that resulted in statistically significant
improvements in evaluation knowledge, skills, and abilities. Post-initiative interviews indicated
CBO preferences for face-to-face training in logic model development, mixed method data
collection and analysis.
Conclusion—This report illustrates the use of mixed methods to plan, implement and evaluate a
model to catalyze CBOs systematic assessment of prevention initiatives and considerations in
evaluation capacity-building.
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The HIV/AIDS epidemic continues to adversely affect communities throughout the United
States, particularly communities in the Southern region. While the estimated number of new
AIDS cases in the nation and the South remained stable between 2005 and 2008, the
Southern region continued to have the highest estimated number of new AIDS cases of any
U.S. region and the highest estimated number of people living with AIDS during this
period.1 Florida, Georgia, and Louisiana were among the states with the highest rates of
people living with a diagnosis of HIV infection between 2006 and 2009.2
While community-based organizations (CBOs) serve as catalysts for HIV/AIDS prevention
and treatment activities, many do not consistently evaluate their programs, limiting the
degree to which the effectiveness of interventions can be measured.3–8 Increased
accountability by funders and the public health emphasis on evidence-based interventions
have heightened the importance of evaluation skills among CBOs.8–11 As a result, the
sustainability of promising programs is increasingly contingent on evidence of
programmatic successes.
Evaluation capacity is characterized by the degree of evaluation skills through recognition of
the utility of monitoring and assessment through an organizational culture that incorporates
it into program design and implementation efforts.12–21 Evaluation capacity serves to
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strengthen a program’s ability to consistently measure success, make programmatic
improvements, and provide funders with evidence of good fiscal stewardship. The
development of measurable indicators, replicable implementation plans, and systematic,
data-driven programs are among the benefits of evaluation skill development.
Factors gauging the degree of consistent CBO evaluation practice are associated with other
well-recognized challenges to program delivery including limited time, funding and
staff.22–24 Other obstacles to evaluation practice include perceptions of a disconnect
between service delivery and evaluation, the fear of negative interpretation of evaluation
results, and lack of confidence in the accuracy of evaluation findings.24 Data collection and
analysis skills, technical assistance needs, and access to technology are also cited as barriers
to evaluation practice.23 Building evaluation capacity is more effective when preceded by a
review of a program’s infrastructure, implementation model, and resources (human and
fiscal) for monitoring progress. Evaluability assessment is at the center of developing a
formative inventory for targeted evaluation capacity-building.
Evaluability assessment (EA) is a critical evaluation planning method designed to support
the feasibility of program assessment prior to program implementation. This is particularly
valuable among CBOs, who operate in fluid internal and community contexts. Over the past
twenty years, EA has been used to identify the degree to which a program is ready for
evaluation as well as for establishing of goals and objectives based on stakeholder input and
consensus.25 Evaluability assessment processes include face to face interviews, meetings or
site visits to understand program contexts, and the review of program documents to
determine how curriculum content and other programmatic components are evaluated in real
time.25–28 Frequently at the center of EA outcomes is the drafting, review, and
establishment of a program logic model and working with program staff people to identify
the resources and support to implement and evaluate it.27
Evaluability assessment and evaluation capacity are distinguishable in that the former should
precede and determine the need for the latter. Evaluability assessment is at the center of
developing a formative inventory for targeted evaluation capacity-building. In the frequently
resource-challenged environments of CBOs, identification of the plan and system in place
for evaluation of a program is critical to determining the evaluation capacity needs of the
intervention team.
The Pfizer Foundation funded CBOs between 2004 and 2007 (Pfizer Grantees) conducting
HIV primary and secondary prevention activities in the states of Alabama, Florida, Georgia,
Louisiana, Mississippi, North Carolina, South Carolina, Tennessee, and Texas. Community-
based organizations were small to mid-size organizations with as few as two full-time paid
staff and as many as 40 unpaid volunteer staff. All annual budgets were less than $1 million.
Twenty-four CBOs were initially funded. Twenty-three re-applied and were successfully re-
funded in 2005; 20 received continuation funding in 2006. Organizations had established
partnerships with health facilities, academic institutions and faith-based organizations. Most
intervened with specific racial/ethnic groups while maintaining services or interventions for
other groups. The special populations that were served included peer educators, youth
attending community organizations, middle and high school students, those in substance
abuse recovery, counseling and recovery.28
Current study
A three-partner collaborative was then developed to identify, prioritize and respond to
evaluation capacity needs of community-based organizations (CBOs) conducting HIV
primary and secondary prevention. First, The Morehouse School of Medicine Prevention
Research Center (MSM PRC) Evaluation brought a participatory evaluation approach,
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expertise in qualitative and quantitative evaluation and cultural competence in community-
based research to the partnership. Second, The Pfizer Foundation Southern HIV/AIDS
Prevention Initiative (Pfizer Initiative) represented an organizational will and fiscal capacity
to support CBOs conducting HIV prevention in the South. Third, Pfizer Initiative-funded
CBOs (Pfizer Grantees), supported by funds up to $55,000, were central partners, bringing
innovative approaches to sexual health promotion and HIV prevention, and a direct link to
communities and stakeholders. The purpose of this article is to report the process of
community-campus engagement in an initiative developed to understand and build
evaluation capacities of promising community-based organizations.
Methods
Evaluability assessment
Step One. Semi-structured teleconference interviews were conducted between June and
August 2004 with each Pfizer Grantee to gain a clearer understanding of proposed program
implementation, evaluation plans, and program contexts. Central to these discussions were
grant proposals submitted and funded by the Pfizer Initiative.28 Teleconferences were
developed 1) to gain insight into how programs may have evolved in scope, goals and
objectives since the initial proposal submission; 2) to identify how program success would
be defined; 3) to assess intervention data needs, current data collection methods and
procedures; 4) to identify how collected data would be used to assess program success; and
5) to determine technical assistance needs. This process was critical in order to determine
whether each CBO was prepared to engage in evaluation capacity-building and cross-site
assessment. A by-product was identification of each organization’s perceptions of the links
between program components and outcomes, as well as the organizational and community
factors that moderate program function.
Step Two. The MSM PRC assisted each Pfizer Grantee in the development of a logic model
specific to their program needs and foci. The logic model conceptualization provides a
blueprint for developing a clear connection between program components, facilitates timely
monitoring of planned activities, and illustrates the order of events necessary for successful
achievement of objectives.29–34 A logic model is a conceptual and visual depiction of a
program’s goals, inputs, strategies, outputs, outcomes, objectives, and the assumed causal
relationship between them. A major strength of logic models is their utility in illustrating the
linkages between existing conditions, activities, outcomes and effects. Each element should
be guided and informed by community stakeholders, among others, to ensure that both
community needs and assets are understood and that activities are realistic and appropriate
for the community context.35 Logic model development is important to evaluability
assessment because it supports determination of whether programs have intentionally
thought through the connection between their effort and anticipated outcomes. Preliminary
logic models were drafted by the MSM PRC based on program descriptions submitted in
initial funding applications and semi-structured teleconference interviews.
Step Three. Site visits were conducted by MSM PRC trained evaluators July to September
2004 to gain a first-hand perspective into the contexts in which each Pfizer Grantee existed.
Meetings with key administrative staff, program staff and target audiences provided a two-
way learning opportunity for the MSM PRC and CBOs 1) to establish trust among key
stakeholders; 2) to engage in dialogue and to review documents critical to assessing
evaluation capacities, including drafted logic models; and 3) to discuss technical assistance
related to Pfizer Initiative evaluation requirements. Logic models drafted by the MSM PRC
were also revised and approved by each Pfizer Grantee during site-visits to ensure that they
accurately reflected program components and success indicators. Table 1 includes results of
the EA process that advised evaluation capacity-building activities.
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Each step in the evaluability assessment was systematically staged to build upon each other
in preparation for evaluation capacity-building through understanding of each CBO’s
program and evaluation context. Employing a one-size-does-not-fit-all approach, the semi-
structured interviews engaged each CBO to better understand evaluation TA needs, as well
as to contribute to identifying content for cross-site evaluation capacity-building
implementation. The information gathered through each interview was used to develop the
drafted logic model representing each program’s activities and to link program success and
its measurement. Site visits were conducted to not only confirm the accuracy of the logic
model drafted by the MSM PRC with CBO program staff, but to establish trust, positive
rapport, and to identify local program stakeholders that would be engaged in the Pfizer
Initiative over time. As detailed by Painter et al., the exercise of EA lies in its ability to
explore (compare and contrast) perspective of the program among program stakeholders,
defining the programs logic, and defining program achievements towards the development
of more useful and culturally relevant evaluation.6 Figure 1 includes each step in the EA
process, how each preceding step informed the next towards the development of evaluation
capacity-building implementation (Step 4).
Evaluation capacity-building and measurement
Step Four. Morehouse School of Medicine PRC used EA results to develop evaluation
capacity-building content and subsequent implementation. The MSM PRC rationale for
development of targeted approaches, advised by the EA, that are tailored to community-
stakeholders is supported in the literature, which indicates that the design of activities must
account for, among other elements, ECB participant characteristics, assessing their
organizational resources.36–37 Pfizer Grantee executive directors and program staff members
were actively engaged in formal didactic presentations, in-person training workshops,
teleconferences, and web conferences (all with feedback and discussion sessions) designed
to enhance capabilities to plan, implement, and evaluate their community-level interventions
to prevent HIV/AIDS. Capacity-building used a participatory evaluation framework with all
sessions offering interactive opportunities to apply learning to funded interventions and
discussions to maximize inputs through opportunities for questions and answers, reflection
on and application to program implementation challenges and experiences.22,34,38 Table 1
contains the schedule and content description of evaluation capacity-building provided.
As part of its overall evaluation, MSM PRC developed and conducted an initial cross-site
program assessment survey (C-PAS) of the CBOs to determine their knowledge, skills, and
abilities for planning and conducting community interventions and their technical needs.26
The C-PAS was adapted from a previous instrument used successfully in substance abuse
intervention training, pretested among MSM PRC community coalition board members, and
reviewed and modified prior to administration.38
The C-PAS questionnaire was designed to be completed in 15–20 minutes and to capture the
key personnel’s self-reported knowledge and skills relating to key steps in developing,
implementing, and evaluating a community-based intervention as well as the organization’s
specific abilities to perform essential functions. We used knowledge to refer to the
individual understanding of queried activities and skills to represent individual proficiency
to perform certain activities. Knowledge and skills were measured on a five-point Likert
scale using the six key variable constructs of community program planning and
implementation: problem identification, needs assessment, developing goals and objectives,
gathering program input and feedback, prevention implementation planning and evaluation
of community intervention. Technical assistance needs were assessed (as a yes/no variable)
for the following: logic model development, data collection tool development, data
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management, protocol development, qualitative and quantitative methods, and evaluation.
Table 2 provides examples of questions including the C-PAS questionnaire.
The C-PAS was initially administered February 2005 and at two subsequent time points to
determine changes in knowledge, skills, abilities, and technical needs prior to each capacity-
building effort during the Initiative. Self-administered questionnaires were sent to each
organizational designee by U.S. and electronic mail to gain varying perspectives on program
processes. Pfizer Grantees received two U.S. mail reminders and one telephone reminder to
return surveys. The survey response rate was 84.8% for the first C-PAS, 78.3% for the
second C-PAS and 93.2% for the third C-PAS. Differences in responses among executive
directors and primary program staff people were combined due to non-significant
differences between groups.
Pfizer grantee perspectives of evaluation capacity-building partnership process
Following completion of all evaluation-capacity-building activities, MSM PRC conducted
one-on-one semi-structured teleconferences from September to December 2006 with each
Pfizer Grantee to gather feedback on the evaluation capacity-building partnership
throughout the Initiative and continued challenges and technical assistance to be overcome
as they worked to implement new competencies after the Initiative’s conclusion.
Teleconferences were conducted with each Pfizer Grantee organization between October
and December 2006. Twenty Pfizer Grantees participated in the teleconference, resulting in
a 91% participation rate. Each teleconference was taped with prior permission of
participants and transcribed. Qualitative data analysis was conducted by two reviewers, who
independently identified trends and themes in responses for teleconferences.
Results
Evaluability assessment
Evaluability assessment helped to identify areas for targeted evaluation capacity-building
among Pfizer Grantees. Challenges identified during this first step were the evidence-base
for the development of evaluation capacity-building activities for the duration of Pfizer
Initiative. Each area described below represents identified challenges. Table 3 details each
identified challenge that was addressed.
Evaluation capacity-building assessment
Comprehensive C-PAS results have been detailed elsewhere and are briefly highlighted here
to indicate key successes in implementation and to provide context associated with the
implementation of community-engaged model and its associated results.34 They indicate a
steady positive progression in CBO’s abilities to plan, implement and evaluate programs.
Further, technical assistance needs significantly decreased from 48.7% for logic model
development from the initial C-PAS to 27.8% for the second CPAS and 12.2% for the third
C-PAS (p=.002). The technical assistance needs for utilizing qualitative and quantitative
methods also decreased, from 64.1% in the first C-PAS to 50.0% and 36.3% in the second
and third C-PAS, respectively (p=.048). Evaluation development technical assistance needs
decreased from 84.6% at the initial C-PAS to 63.9% in the second C-PAS and 39.0% in the
third C-PAS (p<.001). Table 4 includes a sample of questions included in the C-PAS
questionnaire.
Table 4 details composite scores for knowledge, skills, and abilities measured across each
administration of the C-PAS. Individual knowledge scores, among those in the composite,
associated with evaluation indicated significant increases for goal and objective
development at the second and third C-PAS (p=.045). Among individual ability scores in the
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composite, developing data collection tools (p=.002) and analyzing collected data (p=.011)
indicated significant increases across C-PAS administrations.
Post-evaluation capacity-building Pfizer grantee semi-structured interviews
Pfizer Grantee organizations were asked to describe the aspect(s) of evaluation capacity-
building activities provided by the MSM PRC as a means through which the MSM PRC
could identify the strengths and challenges of its ECB model. The training format preferred
by most Pfizer Grantees was face-to-face conferences (cited 14 times). Hands-on application
and networking were valued characteristics of the face-to-face format. The quotations below
represent the perspectives of Grantees on the process.
Okay, definitely the face-to-face are much, much, much more effective …. They
just are. I don’t think you can really make up for being together in the same room
sharing. It’s just so much more education that way. I know it’s much more
expensive to do things that way but it really is the thing that works the best.
…I’d say the hands-on application …because we had opportunities to participate in
several group-related activities to apply some of the information that we’ve learned
just with each other but also knowing how to bring back once we got back to our
individual sites.
…Cause I think you get more and plus you’re focused then. On teleconferences no
matter how much you’re trying to not have other stuff around you it’s hard to keep
that away.
Organizations identified data entry training, logic model training, and qualitative training,
respectively, as the most valuable preferred content areas offered by MSM PRC in
evaluation capacity-building activities.
Epi Info …that was that thing that we’re going to be using more than anything else
because what we needed was to have a way of collecting data that was simple and
efficient and that anybody could utilize and anyone can use.
The other thing is the logic model of the subjects that we learned, that was the one
that is most effective and that we needed to know more than anything else because
that’s something that we can use for other grants and other programs and it helps us
set up our programs in a logical fashion that shows effective change and then the
other thing is that the last conference we were talking about data collection and
things like that at the conference.
Well, the logic models was the best thing that happened and the fact that it was
insisted and stressed so much at every meeting and every encounter that we had
with [MSM PRC] I think it was great. Plus it’s easy for us [not] to develop a logic
model for other programs that we had or programs that we wanted to implement.
Pfizer Grantees were asked if there were areas specific to their organizations that continue to
be program evaluation challenges. Most discussed program evaluation challenges related to
data collection, entry, and analysis.
All that [data] is handwritten now and how we could capture that on a form and
then it in a system that we can sort of look at is our challenge.
Yeah I would say the data input. We’re just very small. We don’t have anyone. It is
partly our fault too but it’s an area that we constantly face [as] a challenge.
…Looking at having a consistent model to track our staff so they have better
understanding—our entire staff-so they have a better understanding of data
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collection and analysis and then have regular like quarterly opportunities to review
data, to analyze it and to reflect on it as a staff.
Organizational and staff resources were all cited challenges faced by Pfizer Grantees when
considering the priority of evaluation. Many expressed program evaluation challenges
surrounding staff and resources and staff involvement and buy-in.
Well there is a cap, there is a 7% cap on the amount of money, federal money, that
you can use in your agency for administration. So if you can imagine you have a
$100,000 grant but you can only use 7% of it for any of your infrastructure, any of
your data collection and all of that doesn’t count, it makes it very, very difficult
because they don’t want you spending their money on [evaluation] …many of our
agencies run with this Catch-22.
…A couple of us [are] no longer here and I have myself but there’s only a couple
of people with the organization that understand what evaluation is, what its value
is, why we do it and the fact of the matters is if the staff doesn’t understand and
appreciate evaluation …. So I think that talking about evaluation with our whole
staff is important because they’re the ones that are going to input the data. They’re
the ones that are going to be collecting this.
I think our biggest challenge is time or being understaffed here and it’s hard to
really allocate the time to do this because it is important and it’s hard to take the
time and do it when you have so much else to do ….
Discussion
The mixed-method approach employed by the MSM PRC provided an evidence based
model by which to assess both the processes and outcome of community-engaged evaluation
capacity-building. The C-PAS indicated significant improvement, as previously noted,
among Pfizer Grantees to plan, conduct, and evaluate interventions and significantly
decreased technical assistance needs directly before evaluation capacity-building events
began, with follow-up assessment after one year, and at the conclusion of evaluation
capacity-building activities. Following the conclusion of evaluation capacity-building
activities, 2006 Pfizer Grantee semi-structured interviews were a critical process through
which the MSM PRC could conclude evaluation capacity-building activities with
perspectives and perceptions of the Pfizer Grantees, the target audience for whom the
Initiative was developed. Organizations considering similar initiatives should consider the
follow recommendations detailed below when planning their own support capacity-building
work among similar CBOs.
Conduct systematic evaluability assessment throughout the course of funding support
Assessment should be on-going in order to increase the likelihood of local evaluation buy-in
and the diffusion of skills, knowledge and abilities within organizations. In addition to
limited resources (human, fiscal and time), many organizations experience high staff
turnover at the administrative and support levels. Participants in capacity-building activities
during the first year of a project may no longer be involved in projects by the funding
cycle’s conclusion. This may affect the degree of improvement in evaluation capacity. On-
going assessment will also help in the design of training activities that can reasonably
accommodate the format and content preferences of participants.
Adopt practical, hands-on learning opportunities for adult learners
Pfizer Grantees preferred methods that would be most relevant to their current programmatic
needs, rather than those that were abstract or perceived as “academic.” Sensitivity to the
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balance between theoretical relevance of reliable and valid evaluation measures must be
coupled with a respect for the resources and value-added from the perspective of the target
audiences. Some organizations reported the value of electronic tools and templates that
could also be conveniently used at their local organizations such that they would not, as they
said “have to reinvent the wheel.”
Employ quantitative and qualitative methods to measure the success of program
processes and outcomes
Knowledge, ability and skill acquisition are often challenged by the contexts within which
programs are implemented. While quantitative (e.g., survey) data provide a perspective that
is frequently said to be more objective, qualitative data collected from the target audiences,
through teleconferences, focus groups and open-ended questions help to shed light on what
the data means. Both methods can be used together to develop the most effective strategies
which are tailored and informed by the unique needs of recipients.
Offer or facilitate on-going technical support
While Pfizer Grantees have made important strides in evaluation capacity, it has been
incremental and operationalized within the contexts of staff turnover, the competing
demands of stakeholders, and among other priorities. Organizations have stressed the
importance of offering program-specific support in areas including data entry, management
and analysis. Programs may alternatively be offered resources through which they can
access free or low cost trainings or on-line modules that can be shared with other program
staff in order to institutionalize evaluation skills within their organizations.
Conclusion
Evaluability assessment, capacity-building activities and qualitative assessment show that
evaluation capacity-building is an iterative process, requiring partnerships between funders,
evaluators and grantees over time to fine-tune strategies in an audience-targeted manner
because one size does not fit all. Current trends in community-based participatory research
and evaluation encourage the empowerment of community organizations to understand,
plan, and conduct local evaluation efforts. The process toward these practices necessitates
the acquisition of practical skills that are valued within each organization and become part
of all programmatic activities. The benefits of evaluation skill development and buy-in
include the development of measurable indicators, replicable implementation and evaluation
plans, and dissemination of systematic, data-driven results, greatly influencing a program’s
likelihood of sustainability. While processes, outcomes and recommendations described in
this article represent a community-campus partnership to strengthen small to mid-sized
community-based organizations (organizations with annual revenues of less than $1 million)
conducting HIV/AIDS prevention in the South, this model may be adapted to similar
partnerships with organizations that are addressing other chronic health disparities. Stated
differently, strategic community-based participatory approaches, including evaluability
assessment and evidence-based capacity-building initiatives are relevant approaches to
consider to increase the likelihood of ownership and buying in evaluation partnerships with
CBOs.
The MSM PRC seeks to identify the degree to which programs are achieving developed
goals and objectives and to enhance the skills critical to planning, implementing, and
evaluating programs for increased program effectiveness and sustainability. This report
represents evaluation measures, interactions and processes that were integral to increased
evaluation capacity, as measured by results of the Cross-site Program Assessment Survey
(see Table 4). It is anticipated that the dissemination of cross-site program assessment and
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capacity-building activities will help to inform and improve the quality of measurable,
replicable evidence-based HIV/AIDS prevention programs.
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Figure 1.
Evaluability assessment and evaluation capacity-building steps.
CBO = Community based organizations
MSM-PRC = Morehouse School of Medicine—Prevention Research Center
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Table 1
CBO EVALUABILITY ASSESSMENT RESULTS
Evaluability Challenge Opportunity for Capacity-building
Development of Measurable
Change Objectives
While there was a clear articulation of outputs, or the products of each strategy or activity (i.e., the number
of peer educators trained, condoms distributed). Very few identified measurable objectives to gauge short-
or mid-term change resulting from these efforts. Outcome-based evaluation requires systematic collection
of data that will capture desired change, beyond the documenting of numbers of activities and related
products.
Selection/Revision of Methods
and Tools to Measure Progress
and Desired Outcomes
Several Pfizer Grantees expressed the desire to revise or amend existing data collection tools to assess not
only HIV knowledge but risk perceptions or behavioral intentions among prioritized target populations.
Further, few had used both qualitative and quantitative data to measure processes and outcomes
Data Collection, Storage and
Analysis
Limited evaluation accountability in previously funded programs, limited time and staff to spend on
systematic data collection or entry were among reasons cited for little or no systematic data management
systems. Further, most did not have an electronic database for survey data collected. These factors limited
the degree to which data quality checks, and subsequent data analysis could be conducted to assess
interventions.
J Health Care Poor Underserved. Author manuscript; available in PMC 2014 February 06.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Akintobi et al. Page 14
Table 2
CROSS-SITE PROGRAM ASSESSMENT SURVEY (C-PAS) SAMPLE QUESTIONS
Question Answer Choices
Please rate your organization’s ability to:
• Develop data collection tools
• Conduct focus groups
• Enter collected data into the computer analyze collected data
On a scale of 1 (Low) to 5 (High)
Please indicate your current level of skill (knowledge or ability, respectively) related to each of the
following steps in community program development:
• Development of goals and objectives
• Data Management
• Qualitative Methods
1 = None, 2 = Little, 3 = Some, 4 =
A lot, 5 = Extensive
Please indicate all technical assistance needs:
• Logic model development to help chart a clearly visible path or program planning
• Data Management
• Data Collection Tool Development
• Protocol Development to increase consistent data collection, management and analysis
• Qualitative/Quantitative methods to learn the best ways to measure expected changes
Yes or No
C-PAS = Cross-site program assessment survey
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Table 3
CBO EVALUATION CAPACITY-BUILDING AND MEASUREMENT SCHEDULE 2004–2006
Activity Description
Pfizer Foundation Southern HIV/
AIDS Prevention Initiative
Orientation to Evaluation, June 2,
2004
An introduction to evaluation philosophy and methods and procedures of community intervention
planning, implementation, and evaluation.
1st cross-site program assessment
survey (C-PAS) conducted: February–
March 2005
Baseline Assessment
Cross-site Evaluation Teleconferences
and Site Visits, Fall 2004
Conducted teleconference with each grantee to gain better insights into the background of the
programs, current status of intervention(s) development, and future plans. Subsequent site visits to
each organization were also conducted by a member of the evaluation team and a member from Pfizer
to gain additional insights of organizations environments, HIV/AIDS and other programs.
Training Workshop, May 11–12, 2005 Conducted in response to identified evaluation challenges and capacity-building needs during project
year 2004, including data collection methods, tools, and analysis; database development; and logic
model review.
Training Teleconferences, April–
August 2005
A total of 12 teleconferences were designed and conducted to facilitate evaluation capacity-building
opportunities through (a) reinforcement of intervention skills attained, (b) provision of an outlet for
evaluation resource-sharing, and (c) discussion of real-time evaluation case studies that may be
applied to individual program activities.
2nd C-PAS conducted: February–
March 2006
Follow-up Assessment 1
Training Conference, June 14–16,
2006
Provided in-depth training in areas identified through evaluation of C-PAS findings, capacity-building
activities, and feedback from grantees, including developing survey questions and focus group guides;
qualitative and quantitative data entry, management, and analysis; and use of collected data.
Training Web Conferences, March
and August, 2006
Two capacity-building training web conferences were developed and facilitated Year 3, designed to
prepare grantees for sustained programmatic and evaluation activities beyond the last year of the
initiative. Each web conference was offered twice, on separate days, to allow for small group
interaction among 9–11 grantees, and to accommodate scheduling needs.
Program Assessment Teleconferences,
August 9–10, 2006
One-on-one, semi-structured teleconferences were conducted to gain better insight into grantees’
technical assistance needs for completion of the 2006 Program Assessment and continued evaluation
challenges that remain at the conclusion of the initiative.
3rd C-PAS conducted: September–
October 2006
Final Assessment
CBO = Community based organizations
C-PAS = Cross-site program assessment survey
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Table 4
CROSS-SITE PROGRA M ASSESSMENT SURVEY (C-PAS) SKILL, KNOWLEDGE AND ABILITY
SUMMARY SCORES
C-PAS
Administrations
Skilla
Median (IQR)
Knowledgea
Median (IQR)
Abilityb
Mean (S.D.)
1st (n=39) 2.83 (0.67) 2.83 (1.33) 3.88 ± 0.42
2nd (n=36) 3.00 (0.75) 3.00 (0.66) 4.07 ± 0.45
3rd (n=41) 3.16 (0.83)c 3.17 (0.34)d 4.21 ± 0.46e
aSkills and knowledge based on a five-point Likert scale of 0 (none) to 4 (extensive); summary score of six items.
bAbilities based on a five-point Likert scale of 1 (low) to 5 (high);summary score of 20 items.
cOverall trend in higher summary skills scores is not statistically significant, p=.057.
dOverall trend in higher summary knowledge scores is statistically significant, p=.022.
eOverall trend in higher summary abilities scores is statistically significant, p=.0004.
IQR = Interquartile Range
SD = Standard Deviation
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